1. ScholarBank@NUS

LIM SENG GEE

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
LIM SENG GEE
Variants
Lee Lim, S.G.
Lim, S.G.
Seng, Foreword Gee Lim
Seng, G.L.
Lim Seng Gee
Lim, Seng Gee
Lim, S.-G.
 
Main Affiliation
 
Faculty
 
Email
mdclimsg@nus.edu.sg
 

Publications

Results 1-20 of 146 (Search time: 0.183 seconds).

Issue DateTitleAuthor(s)
120082-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesisZubaidah, R.M. ; Chung, M.C.M. ; Gek, S.T.; Tan, S.B.E.; Lin, Q. ; Seng, G.L. 
220082-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesisZubaidah, R.M. ; Chung, M.C.M. ; Gek, S.T.; Tan, S.B.E. ; Lin, Q. ; Seng, G.L. 
32006A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BLim, S.G. ; Ng, T.M.; Guan, R.; Kung, N.; Krastev, Z.; Volfova, M.; Husa, P.; Lee, S.S.; Chan, S.; Shiffman, M.L.; Washington, M.K.; Rigney, A.; Anderson, J.; Mondou, E.; Snow, A.; Sorbel, J.; Rousseau, F.
42010A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis BTan, A.T.; Koh, S.; Goh, W.; Gehring, A.J.; Bertoletti, A. ; Lim, S.G. ; Zhe, H.Y.
52008A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)Lee, Y.-M. ; Sutedja, D.S.; Dan, Y.-Y. ; Aung, M.-O. ; Zhou, L. ; Lim, S.-G. ; Cheng, C.-L.; Wee, A. ; Wai, C.-T. 
6Jun-2008A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)Lee, Y.-M. ; Sutedja, D.S.; Wai, C.-T. ; Dan, Y.-Y. ; Aung, M.-O. ; Zhou, L. ; Cheng, C.-L.; Wee, A.; Lim, S.-G. 
72006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E.; Bowden, S.; Locarnini, S.; Ishaque, S.M.
82006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E. ; Bowden, S.; Locarnini, S.; Ishaque, S.M.
92004Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplantWai, C.-T.; Prabhakaran, K. ; Wee, A. ; Lee, Y.-M.; Dan, Y.-Y.; Sutedja, D.S.; Mak, K.; Isaac, J. ; Lee, K.-H. ; Lee, H.-L.; Da, Costa M. ; Lim, S.-G. 
102003Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis BHadziyannis, S.J.; Tassopoulos, N.C.; Heathcote, E.J.; Chang, T.-T.; Kitis, G.; Rizzetto, M.; Marcellin, P.; Lim, S.G. ; Goodman, Z.; Wulfsohn, M.S.; Xiong, S.; Fry, J.; Brosgart, C.L.
112003Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis BMarcellin, P.; Chang, T.-T.; Lim, S.G. ; Tong, M.J.; Sievert, W.; Shiffman, M.L.; Jeffers, L.; Goodman, Z.; Wulfsohn, M.S.; Xiong, S.; Fry, J.; Brosgart, C.L.
12Aug-2007Age in Guiding Strategy in Hepatitis A VaccinationWai, C.-T. ; Mak, B.; Aung, M.O. ; Lim, S.-G. 
132003An anti-HIV-1 gp120 antibody expressed as an endocytotic transmembrane protein mediates internalization of HIV-1Tan, Y.-J.; Lim, S.-P.; Ting, A.E.; Goh, P.-Y.; Tan, Y.H.; Lim, S.G. ; Hong, W.
14Apr-2012APASL consensus statements and management algorithms for hepatitis C virus infectionOmata, M.; Kanda, T.; Yu, M.-L.; Yokosuka, O.; Lim, S.-G. ; Jafri, W.; Tateishi, R.; Hamid, S.S.; Chuang, W.-L.; Chutaputti, A.; Wei, L.; Sollano, J.; Sarin, S.K.; Kao, J.-H.; McCaughan, G.W.
152007Applicability of cost-effectiveness analysis to management of chronic hepatitis BDan, Y.Y.; Lim, S.G. 
162006Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?Cheng, Y. ; Seet, B.L.; Ong, C.S.L.; Wasser, S. ; Lim, S.G. ; Tan, T.M.C. ; Peter, F.J. 
172010Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaOmata, M.; Tateishi, R.; Yoshida, H.; Shiina, S.; Lesmana, L.A.; Budihusodo, U.; Lesmana, C.R.; Chen, P.-J.; Lin, S.-M.; Liaw, Y.F.; Kudo, M.; Lee, J.M.; Choi, B.I.; Poon, R.T.P.; Cheng, A.L.; Jia, J.-D.; Obi, S.; Han, K.H.; Jafri, W.; Chow, P.; Lim, S.G. ; Chawla, Y.K.; Gani, R.A.; Putranto, T.A.; Sarin, S.K.
18Jul-2009Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis BZeuzem, S.; Gane, E.; Liaw, Y.-F.; Lim, S.G. ; DiBisceglie, A.; Buti, M.; Chutaputti, A.; Rasenack, J.; Hou, J.; O'Brien, C.; Nguyen, T.T.; Jia, J.; Poynard, T.; Belanger, B.; Bao, W.; Naoumov, N.V.
192005Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 yearLee, Y.-M. ; Wai, C.-T. ; Da, Costa M. ; Lee, K.-H.; Sutedja, D.; Tan, K.-C.; Isaac, J. ; Lim, S.-G. 
202005Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 yearLee, Y.-M. ; Wai, C.-T. ; Da, Costa M. ; Lee, K.-H. ; Sutedja, D.; Tan, K.-C.; Isaac, J. ; Lim, S.-G.